InSysBio to announce a new collaborative project with BeOne Medicines

The project aims at Quantitative Systems Pharmacology modeling of a T-cell engager to identify first-in-human dose and predict optimal step-up dosing regimen

Kayentis and Ametris join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials

Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance

Epigenica Launches EpiFinder™ Analysis Service, a Fully Managed Platform for Fast and Reliable Epigenomic Insights

Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform.

Astoriom Acquires Precision Stability Storage

• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America • Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations

Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director

Ceryx has strengthened its Board of Directors with the appointment of Mark Strong.

START Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evaluating a novel combination therapy for patients with locally advanced or metastatic urothelial carcinoma (mUC), including bladder cancer, and represents an important step forward in 4D Path’s mission to redefine precision oncology.

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).

Hovione’s people-first approach recognized as it achieves Top Employer certification for the fourth consecutive year

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.

VoxCell appoints Chief Commercial Officer as Demand Grows for Predictive, Human-Relevant, Non-Clinical Testing Approaches

ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

Kindeva Announces Leadership Transition to Drive Strategic Growth

PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection

The PHCbi TwinGuard® ECO freezer ultra-low temperature (ULT) freezer is engineered to deliver enhanced energy efficiency and expanded operational monitoring for biorepositories, biopharmaceutical companies, and academic institutions.

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

Supports customers with real-time clinical intelligence activation through Viz.ai’s integrated clinical workflows, triggers, and compliant orchestration services for Agentforce.

Advanced Health Selects 1upHealth to Lead Interoperability Initiatives

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT’s firefly platform

Sapio Sciences announces partner ecosystem for ELaiN, its third-generation AI lab notebook

Sapio Sciences has announced a growing partner ecosystem for Sapio ELaiN, its third-generation AI lab notebook, integrating trusted, third-party scientific applications and platforms directly into the workflow. These integrations allow biopharma scientists to use established tools for modeling, analytics and discovery inside ELaiN while maintaining governance, traceability and control.